JOHN GOLDBERG
CIK 2007903 · CHIEF MEDICAL OFFICER · last filed 2025-01-15
JOHN GOLDBERG is a CHIEF MEDICAL OFFICER who has filed 2 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing shows the insider was granted $97.7K of RFL on Jan 15, 2025. Current disclosed insider exposure totals $128.0K across reported positions. 3 SEC filings were submitted jointly with Rafael Holdings, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$128.0K
1
2
$0
Filer Profile
520 BROAD STREET
NEWARK, NJ 07102
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RFL | CHIEF MEDICAL OFFICER | 50,000 | $2.56 | $128.0K | $0 | 2 | 2025-01-15 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-15 | RFL | Grant (A) | +50,000 | $97.7K | EDGAR |
| 2024-01-18 | RFL | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.